xRead - Olfactory Disorders (September 2023)

20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

661

PATEL et al.

polyps: results from the randomized phase 3 sinus-24 study. J Allergy Clin Immunol . 1361. Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol . 2017;140:1024–1031.e14. 1362. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev . 2016;4: CD011991. 1363. Haxel BR, Clemens M, Karaiskaki N, Dippold U, Kettern L, Mann WJ. Controlled trial for long-term low-dose ery thromycin after sinus surgery for chronic rhinosinusitis. Laryngoscope . 2015;125:1048–1055. 1364. Varvyanskaya A, Lopatin A. Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. Int Forum Allergy Rhi nol . 2014;4:533–541. 1365. Dabirmoghaddam P, Seraj JM, Bastaninejad S, Meighani A, Mokhtari Z. The efficacy of clarithromycin in patients with severe nasal polyposis. Acta Med Iran . 2013 51:359–364. 1366. Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long term, low-dose azithromycin in chronic rhinosinusitis: a ran domized controlled trial. Allergy . 2011;66:1457–1468. 1367. Dalgic A, Dinc ME, Ulusoy S, Dizdar D, Is A, Topak M. Com parison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis . 2017;134:213–216. 1368. Stuck BA, Blum A, Hagner AE, Hummel T, Klimek L, Hörmann K. Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis. Allergy . 2003;58:1195. 1369. Meltzer EO. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treat ment of perennial allergic rhinitis. Ann Allergy Asthma Immunol . 1998;81:128–134. 1370. Golding-Wood DG, Holmstrom M, Darby Y, Scadding GK, Lund VJ. The treatment of hyposmia with intranasal steroids. J Laryngol Otol . 1996;110:132–135. 1371. Tansuker D, Coşkun BU, Uçal YO, Sözen E, Erdurak C, Sakalli E. Effects of systemic immunotherapy on olfactory function in allergic rhinitis patients. J Craniofac Surg . 2014;25:e339–e343. 1372. Mun SJ, Shin JM, Han DH, et al. Efficacy and safety of a once daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis. Int Forum Allergy Rhinol . 2013;3:177–183. 1373. Katotomichelakis M, Simopoulos E, Tripsianis G, et al. Improvement of olfactory function for quality of life recovery. Laryngoscope . 2013;123:E10–E16. 1374. Chang H, Han DH, Mo JH, et al. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol . 2009;2:136– 140. 1375. Radcliffe MJ, Lampe FC, Brostoff J. Allergen-specific low dose immunotherapy in perennial allergic rhinitis: A double blind placebo-controlled crossover study. J Investig Allergol Clin Immunol . 1996;6:242–247. 1376. Ecevit MC, Erdag TK, Dogan E, Sutay S. Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study. Laryngoscope . 2015;125:2041–2045.

1342. Rombaux P, Huart C, Collet S, Eloy P, Negoias S, Hummel T. Presence of olfactory event-related potentials predicts recovery in patients with olfactory loss following upper respiratory tract infection. Laryngoscope . 2010;120:2115–2118. 1343. Mobley AS, Rodriguez-Gil DJ, Imamura F, Greer CA. Aging in the olfactory system. Trends Neurosci . 2014;37:77–84. 1344. Watabe-Rudolph M, Begus-Nahrmann Y, Lechel A, et al. Telomere shortening impairs regeneration of the olfactory epithelium in response to injury but not under homeostatic conditions. PLoSOne . 2011;6: e27801. 1345. Brann JH, Firestein SJ. A lifetime of neurogenesis in the olfac tory system. Front Neurosci . 2014;8:182. 1346. Konstantinidis I, Tsakiropoulou E, Bekiaridou P, Kazantzidou C, Constantinidis J. Use of olfactory training in post traumatic and postinfectious olfactory dysfunction. Laryngo scope . 2013;123:E85–E90. 1347. Miwa T, Tsukatani T, Ikeno S, Furukawa M. The effectiveness of Toki-syakuyaku-san for the olfactory disturbed patients. Jpn Assoc Study Taste Smell . 2005;12:523–524. 1348. Shiga H. Post-traumatic olfactory impairment. J Jpn Assoc Odor Environ . 2014;45:278–281. 1349. Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. AmJMedSci . 1976;272:285–299. 1350. Jiang RS, Twu CW, Liang KL. Medical treatment of trau matic anosmia. Otolaryngol Head Neck Surg . 2015;152:954– 958. 1351. Kitano M, Kobayashi M, Miyamura T, Takeuchi K. Prognosti cators for the olfactory dysfunction by head injury. JpnAssoc Study Taste Smell . 2013;3:401–404. 1352. Ikeda K, Sakurada T, Takasaka T, Okitsu T, Yoshida S. Anos mia following head trauma: Preliminary study of steroid treat ment. Tohoku J of Exp Med . 1995;177:343–351. 1353. Jiang RS, Wu SH, Liang KL, Shiao JY, Hsin CH, Su MC. Steroid treatment of posttraumatic anosmia. Eur Arch Otorhinolaryn gol . 2010;267:1563–1567. 1354. Altundag A, Saatci O, Kandemirli SG, et al. Imaging features to predict response to olfactory training in post-traumatic olfactory dysfunction. Laryngoscope . 202; 131: E2243– E2250 1355. Pellegrino R, Han P, Reither N, Hummel T. Effectiveness of olfactory training on different severities of posttraumatic loss of smell. Laryngoscope . 2019;129:1737–1743. 1356. Bromley SM. Smell and taste disorders: A primary care approach. Am Fam Physician . 2000;61:427–436, 438. 1357. Mullol J, Mariño-Sánchez F, Valls M, Alobid I, Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol . 2020;145:773–776. 1358. Schlosser RJ, Smith TL, Mace JC, et al. Factors driving olfac tory loss in patients with chronic rhinosinusitis: a case control study. Int Forum Allergy Rhinol . 2020;10:7–14. 1359. Blomqvist EH, Lundblad L, Anggård A, Haraldsson PO, Stjärne P. A randomized controlled study evaluating medi cal treatment versus surgical treatment in addition to med ical treatment of nasal polyposis. J Allergy Clin Immunol . 2001;107(2):224–228. 1360. Han JK, Bachert C, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal